The Wuhan Institute of Virology has recently filed a patent application for the drug remdesivir to treat coronavirus. The patent was filed jointly with the Military Medicine Institute of the People’s Liberation Army Academy of Military Science. The Chinese believe that remdesivir and chloroquine (an anti-malarial drug) are effective at combating the virus. Chloroquine is an eight year old drug and China is free to manufacture it but remdesivir has been patented by Gilead Sciences Inc. Any production or use of this drug would require sublicensing or approval by Gilead.
China Applies for Patent to Treat Coronavirus
Updated: Aug 24, 2023